Pros and Cons of Iodinated Contrast Media
Proposed Research Question: What are some benefits and dangers of iodinated contrast media administered to CT patient?
sources
References
Bashir, A. A., Kong, V., Skinner, D., Bruce, J., Laing, G., Brysiewicz, P., & Clarke, D. (2019). Contrast-induced nephropathy following CT scan for trauma is not rare and is associated with increased mortality in South African trauma patients. European Journal of Trauma & Emergency Surgery, 45(6), 1129–1135. https://doi-org.databases.msutexas.edu/10.1007/s00068-018-1008-6
González Cervantes, J. J., Mascarós Martínez, J. M., & Arana, E. (2021). Administration of iodinated contrast: What is the risk in cancer patients? European Journal of Cancer Care, 30(1), 1–9. https://doi-org.databases.msutexas.edu/10.1111/ecc.13351
Peet, K., Clarke, S. E., & Costa, A. F. (2019). Hepatic enhancement differences when dosing iodinated contrast media according to total versus lean body weight. Acta Radiologica, 60(7), 807–814. https://doi-org.databases.msutexas.edu/10.1177/0284185118801137
Schmitz, J. J., Jensen, N. M., Kirmse, J. M., Schears, G. J., Yu, L., Williamson, E. E., & Wood, C. P. (2021). Power-Injectable Peripherally Inserted Central Catheter Tip Malposition After Power Injection of Intravenous Contrast Media for Computed Tomography Examinations. Journal of Radiology Nursing, 40(4), 335–338. https://doi-org.databases.msutexas.edu/10.1016/j.jradnu.2021.08.003
Schreuder, S., Stoker, J., Bipat, S., & Schreuder, S. M. (2017). Prediction of presence of kidney disease in patients undergoing intravenous iodinated contrast enhanced computed tomography: a validation study. European Radiology, 27(4), 1613–1621. https://doi-org.databases.msutexas.edu/10.1007/s00330-016-4478-0